| PERIOD ENDING | 26-Sep-09 | 27-Jun-09 | 28-Mar-09 | 27-Dec-08 | | Total Revenue | 44,941 | 56,866 | 53,006 | 65,908 | | Cost of Revenue | 30,726 | 31,637 | 31,211 | 44,437 | | | Gross Profit | 14,215 | 25,229 | 21,795 | 21,471 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 25,066 | 23,912 | 24,324 | 28,218 | | Non Recurring |
-
|
-
|
-
| 2,137 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (10,851) | 1,317 | (2,529) | (8,884) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 51 | 60 | 67 | 94 | | Earnings Before Interest And Taxes | (10,800) | 1,377 | (2,462) | (8,790) | | Interest Expense | 48 | 47 | 51 | 54 | | Income Before Tax | (10,848) | 1,330 | (2,513) | (8,844) | | Income Tax Expense | (4,066) | 486 | (918) | (3,316) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (6,782) | 844 | (1,595) | (5,528) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (6,782) | 844 | (1,595) | (5,528) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($6,782) | $844 | ($1,595) | ($5,528) |
|
0.31% Nasdaq 
0.05%
Income Statement
